How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

Webcast
Karen Conway, Vice President, Healthcare Value at GHX and Mike Schiller, Senior Director of Supply Chain at AHRMM discuss the value of UDI beyond r
Podcasts
Dr. Cherf, Chief Medical Officer at Lumere, and Dr.
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.
Book
This book was written to enhance the strategic contributions of the healthcare supply chain in a way that is most meaningful to hospitals’ an